MedTrace Logo

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

NCT00969111 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-09-09

No results posted yet for this study

Summary

The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.

Conditions

Interventions

RADIATION

IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE

Postop High Risk

RADIATION

Proton (prostate bed) to 70.2 CGE

Salvage Non-High Risk

RADIATION

IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE

Salvage High Risk

RADIATION

Proton to 66.6 CGE

Post-Op Non High Risk

Sponsors & Collaborators

  • University of Florida Health

    collaborator OTHER

  • Proton Collaborative Group

    lead NETWORK

Principal Investigators

  • Randal H Henderson, MD · University of Florida Proton Therapy Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2031-08-31
Completion
2050-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00969111 on ClinicalTrials.gov